304 related articles for article (PubMed ID: 18811133)
1. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
Altenbach RJ; Adair RM; Bettencourt BM; Black LA; Fix-Stenzel SR; Gopalakrishnan SM; Hsieh GC; Liu H; Marsh KC; McPherson MJ; Milicic I; Miller TR; Vortherms TA; Warrior U; Wetter JM; Wishart N; Witte DG; Honore P; Esbenshade TA; Hancock AA; Brioni JD; Cowart MD
J Med Chem; 2008 Oct; 51(20):6571-80. PubMed ID: 18811133
[TBL] [Abstract][Full Text] [Related]
2. Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.
Cowart MD; Altenbach RJ; Liu H; Hsieh GC; Drizin I; Milicic I; Miller TR; Witte DG; Wishart N; Fix-Stenzel SR; McPherson MJ; Adair RM; Wetter JM; Bettencourt BM; Marsh KC; Sullivan JP; Honore P; Esbenshade TA; Brioni JD
J Med Chem; 2008 Oct; 51(20):6547-57. PubMed ID: 18817367
[TBL] [Abstract][Full Text] [Related]
3. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
4. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
[TBL] [Abstract][Full Text] [Related]
5. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
[TBL] [Abstract][Full Text] [Related]
6. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands.
Schreeb A; Walter M; Odadzic D; Schwed JS; Weizel L; Stark H
Pharmazie; 2013 Jul; 68(7):521-5. PubMed ID: 23923631
[TBL] [Abstract][Full Text] [Related]
7. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode.
Engelhardt H; Schultes S; de Graaf C; Nijmeijer S; Vischer HF; Zuiderveld OP; Dobler J; Stachurski K; Mayer M; Arnhof H; Scharn D; Haaksma EE; de Esch IJ; Leurs R
J Med Chem; 2013 Jun; 56(11):4264-76. PubMed ID: 23668417
[TBL] [Abstract][Full Text] [Related]
8. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
[TBL] [Abstract][Full Text] [Related]
9. Histamine H4 receptor ligands and their potential therapeutic applications.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
11. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
[TBL] [Abstract][Full Text] [Related]
12. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
Savall BM; Chavez F; Tays K; Dunford PJ; Cowden JM; Hack MD; Wolin RL; Thurmond RL; Edwards JP
J Med Chem; 2014 Mar; 57(6):2429-39. PubMed ID: 24495018
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).
Masood MA; Selby MD; Bell AS; Mansfield AC; Gardner M; Smith GF; Lane C; Kenyon-Edwards H; Osborne R; Jones RM; Liu WL; Brown CD; Clarke N; Perrucio F; Mowbray CE
Bioorg Med Chem Lett; 2011 Nov; 21(21):6591-5. PubMed ID: 21955944
[TBL] [Abstract][Full Text] [Related]
15. The first potent and selective non-imidazole human histamine H4 receptor antagonists.
Jablonowski JA; Grice CA; Chai W; Dvorak CA; Venable JD; Kwok AK; Ly KS; Wei J; Baker SM; Desai PJ; Jiang W; Wilson SJ; Thurmond RL; Karlsson L; Edwards JP; Lovenberg TW; Carruthers NI
J Med Chem; 2003 Sep; 46(19):3957-60. PubMed ID: 12954048
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
[TBL] [Abstract][Full Text] [Related]
17. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
Kamińska K; Ziemba J; Ner J; Schwed JS; Łażewska D; Więcek M; Karcz T; Olejarz A; Latacz G; Kuder K; Kottke T; Zygmunt M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2015 Oct; 103():238-51. PubMed ID: 26360048
[TBL] [Abstract][Full Text] [Related]
18. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
Andaloussi M; Lim HD; van der Meer T; Sijm M; Poulie CB; de Esch IJ; Leurs R; Smits RA
Bioorg Med Chem Lett; 2013 May; 23(9):2663-70. PubMed ID: 23558237
[TBL] [Abstract][Full Text] [Related]
19. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.
Venable JD; Cai H; Chai W; Dvorak CA; Grice CA; Jablonowski JA; Shah CR; Kwok AK; Ly KS; Pio B; Wei J; Desai PJ; Jiang W; Nguyen S; Ling P; Wilson SJ; Dunford PJ; Thurmond RL; Lovenberg TW; Karlsson L; Carruthers NI; Edwards JP
J Med Chem; 2005 Dec; 48(26):8289-98. PubMed ID: 16366610
[TBL] [Abstract][Full Text] [Related]
20. The effect of pK(a) on pyrimidine/pyridine-derived histamine H4 ligands.
Savall BM; Meduna SP; Venable J; Wei J; Smith RC; Hack MD; Thurmond RL; McGovern P; Edwards JP
Bioorg Med Chem Lett; 2014 Dec; 24(23):5489-92. PubMed ID: 25455490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
